Recent Advances in mRNA Therapeutic Cancer Vaccines

Amy D Laflin1, Jing Pan2, Ming You2

  • 1Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA;

Insights

Therapeutic mRNA cancer vaccines enhance antitumor immunity by delivering tumor antigens and immunostimulants. This review covers current mRNA vaccine therapies, challenges, and future directions for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cancer immunotherapies boost patient immune systems against tumors.
  • Messenger RNA (mRNA) cancer vaccines offer high specificity and safety.
  • mRNA vaccines incorporate tumor antigens to activate T cells.

Purpose of the Study:

  • To review current clinical and preclinical mRNA cancer vaccine therapies.
  • To discuss mRNA encoding immunostimulants as adjuvants or monotherapies.
  • To explore limitations, challenges, and future directions in mRNA cancer vaccine development.

Main Methods:

  • Literature review of clinical and preclinical studies.
  • Analysis of mRNA vaccine strategies using tumor antigens.
  • Examination of mRNA-based immunostimulants in cancer treatment.

Main Results:

  • mRNA vaccines show promise in enhancing tumor antigen-specific T cell responses.
  • mRNA encoding immunostimulants can act as potent vaccine adjuvants.
  • Both antigen-based and immunostimulant-based mRNA therapies are being explored.

Conclusions:

  • Therapeutic mRNA cancer vaccines are a rapidly advancing field.
  • Overcoming challenges is crucial for the clinical success of mRNA cancer vaccines.
  • Future research will focus on optimizing delivery and efficacy for diverse cancers.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K